UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000031455
Receipt number R000035894
Scientific Title The effectiveness of anti-histamine ointment to nasal ala in the patients with allergic rhinitis and bronchial asthma
Date of disclosure of the study information 2018/02/23
Last modified on 2019/07/18 20:32:02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effectiveness of anti-histamine ointment to nasal ala in the patients with allergic rhinitis and bronchial asthma

Acronym

The effectiveness of anti-histamine ointment to nasal ala

Scientific Title

The effectiveness of anti-histamine ointment to nasal ala in the patients with allergic rhinitis and bronchial asthma

Scientific Title:Acronym

The effectiveness of anti-histamine ointment to nasal ala

Region

Japan


Condition

Condition

allergic rhinitis with bronchial asthma

Classification by specialty

Pneumology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effectiveness and saftiness of trans-dermal application of anti-histamnine ointment through nasal ala in the patients with rhinitis and secondary effects to the symptoms of beonchial asthma

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase I


Assessment

Primary outcomes

Subjective effects measured by visual analogue scale and QOLby the patients.

Key secondary outcomes

adverse effects and objective effects measured by pulmonary function test.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Diphenhydramine ointment 0.1FTU (0.04mg) will be applied to nasal ala twice a day for 2 weeks.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

15 years-old <

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

Brinchial asthma patients with active allergic rhinitis.
No change of medications 4 weeks prior to the enrollment.

Key exclusion criteria

Those who have active dermartologic disorders around the nose.
Any changes of medications 4 weeks prior to the enrollment.

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Mitsuhiro
Middle name
Last name Kamimura

Organization

National Hospital Organization Disaster Medical Center

Division name

Department of pulmonology

Zip code

190-0014

Address

Midoricho 3256, Tachikawa, Tokyo, Japan

TEL

042-526-5511

Email

tdmckamimura@yahoo.co.jp


Public contact

Name of contact person

1st name Mitsuhiro
Middle name
Last name Kamimura

Organization

National Hospital Organization Disaster Medical Center

Division name

Department of pulmonology

Zip code

190-0014

Address

Midoricho 3256, Tachikawa, Tokyo, Japan

TEL

042-526-5511

Homepage URL


Email

tdmckamimura@yahoo.co.jp


Sponsor or person

Institute

National Hospital Organization Disaster Medical Center

Institute

Department

Personal name



Funding Source

Organization

National Hospital Organization Disaster Medical Center

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Faculty of Pharmaceutical Sciences, Josai University
Tokai University, Department of Pulmonology

Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Hospital Organization Disaster Medical Center

Address

Midoricho 3256, Tachikawa, Tokyo, Japan

Tel

042-526-5511

Email

tdmckamimura@yahoo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立病院機構災害医療センター


Other administrative information

Date of disclosure of the study information

2018 Year 02 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

10

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 02 Month 10 Day

Date of IRB

2018 Year 02 Month 23 Day

Anticipated trial start date

2018 Year 02 Month 23 Day

Last follow-up date

2019 Year 01 Month 31 Day

Date of closure to data entry

2019 Year 01 Month 31 Day

Date trial data considered complete

2019 Year 01 Month 31 Day

Date analysis concluded

2019 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2018 Year 02 Month 23 Day

Last modified on

2019 Year 07 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035894


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name